English | Español
Patient Daily | Mar 7, 2026

How families can support seniors facing memory-related tech challenges
Patient Daily | Mar 7, 2026

FDA cites design flaws in rejecting REGENXBIO Hunter syndrome gene therapy
Patient Daily | Mar 7, 2026

Boehringer Ingelheim ends MASH partnership with OSE after failed phase 2 trial
Patient Daily | Mar 7, 2026

North Carolina town emerges as key hub for next-gen obesity drug production
Patient Daily | Mar 7, 2026

Experts question centralized decision-making trend at FDA after Moderna vaccine case
Patient Daily | Mar 7, 2026

Cancer survivor credits genetic screening with early Lynch syndrome diagnosis
Patient Daily | Mar 7, 2026

Study finds weighted vests may help preserve bone during weight loss

Patient Daily | Mar 7, 2026

Bedfont Scientific celebrates gender balance for International Women’s Day

Trending
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Revolution and Ascendis identified as top buyout targets amid speculation of industry mega-merger